XML 37 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
2027 Notes
Common Stock
Capital in Excess of Par Value
Capital in Excess of Par Value
Cumulative Effect, Period of Adoption, Adjustment
Capital in Excess of Par Value
Cumulative Effect, Period of Adoption, Adjusted Balance
Capital in Excess of Par Value
2027 Notes
(Accumulated Deficit) Retained Earnings
(Accumulated Deficit) Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
(Accumulated Deficit) Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                          
Balance (in shares) at Dec. 31, 2020         22,983,000                  
Balance at Dec. 31, 2020 $ 188,405       $ 459 $ 243,575       $ (46,706)     $ (3,936) $ (4,987)
Treasury stock (in shares) at Dec. 31, 2020                           1,066,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         105,000                  
Issuance of common stock upon the exercise of stock options 1,156       $ 2 1,154                
Net issuance of restricted stock awards (in shares)         2,000                  
Net issuance of restricted stock units (in shares)         176,000                  
Net issuance of restricted stock units 372       $ 4 368                
Issuance of restricted stock for acquisition (in shares)         1,493,000                  
Issuance of restricted stock for acquisition 110,219       $ 30 110,189                
Treasury stock acquired from employees upon exercise of stock options (in shares)                           115,000
Treasury stock acquired from employees upon exercise of stock options (5,958)                         $ (5,958)
Stock-based compensation 14,615         14,615                
Proceeds from public share offering, net of issuance costs (in shares)         3,335,000                  
Proceeds from public share offering, net of issuance costs 208,172     $ 62,931 $ 67 208,105     $ 62,931          
Foreign currency translation adjustments 232                       232  
Net loss (75,799)                 (75,799)        
Balance (in shares) at Dec. 31, 2021         28,094,000                  
Balance at Dec. 31, 2021 504,345 $ (80,036) $ 424,309   $ 562 640,937 $ (66,656) $ 574,281   (122,505) $ (13,380) $ (135,885) (3,704) $ (10,945)
Treasury stock (in shares) at Dec. 31, 2021                           1,181,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         133,000                  
Issuance of common stock upon the exercise of stock options 1,286       $ 3 1,283                
Net issuance of restricted stock awards (in shares)         200,000                  
Net issuance of restricted stock awards 1       $ 2 (1)                
Issuance of restricted stock for acquisition (in shares)         163,000                  
Issuance of restricted stock for acquisition 6,300       $ 3 6,297                
Treasury stock acquired from employees upon exercise of stock options (in shares)                           90,000
Treasury stock acquired from employees upon exercise of stock options (3,148)                         $ (3,148)
Stock-based compensation 13,426         13,426                
Foreign currency translation adjustments 2,339                       2,339  
Net loss $ (69,319)                 (69,319)        
Balance (in shares) at Dec. 31, 2022 27,319,045       28,590,000                  
Balance at Dec. 31, 2022 $ 375,194       $ 570 595,286       (205,204)     (1,365) $ (14,093)
Treasury stock (in shares) at Dec. 31, 2022 1,270,522                         1,271,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares) 97,000       96,000                  
Issuance of common stock upon the exercise of stock options $ 1,069       $ 2 1,067                
Net issuance of restricted stock awards (in shares)         203,000                  
Net issuance of restricted stock awards 2       $ 2                  
Issuance of common stock for conversion of 2024 Notes (in shares)         497,000                  
Issuance of common stock for conversion of 2024 Notes 14,384       $ 10 14,374                
Treasury stock acquired from employees upon exercise of stock options (in shares)                           85,000
Treasury stock acquired from employees upon exercise of stock options (2,685)                         $ (2,685)
Stock-based compensation 14,427         14,427                
Foreign currency translation adjustments 426                       426  
Net loss $ (69,752)                 (69,752)        
Balance (in shares) at Dec. 31, 2023 28,029,915       29,386,000                  
Balance at Dec. 31, 2023 $ 333,065       $ 584 $ 625,154       $ (274,956)     $ (939) $ (16,778)
Treasury stock (in shares) at Dec. 31, 2023 1,356,319                         1,356,000